@ARTICLE{
author={Perzeri Andreas L,...,Bogdanovic Andrija D,...,(broj koautora 20)},
year={2010},
title={High Dose Imatinib Induction Therapy (800 mg/day, 6 Months) In Pre-Treated Chronic Phase CML Patients Improves Cytogenetic and Molecular Responses but Does Not Improve Overall and Progression Free Survival - Final Results of the CELSG Phase III CML11 "ISTAHIT" Trial},
journal={BLOOD},
volume={116},
number={21},
pages={934-935},
document_type={Meeting Abstract},
}